4//SEC Filing
REESE ALBERT L JR 4
Accession 0001855763-24-000006
CIK 0001348362other
Filed
May 9, 8:00 PM ET
Accepted
May 10, 4:52 PM ET
Size
10.7 KB
Accession
0001855763-24-000006
Insider Transaction Report
Form 4
REESE ALBERT L JR
Director
Transactions
- Award
Stock Options
2024-04-26+5,000→ 20,000 totalExercise: $2.36From: 2024-04-26Exp: 2029-04-26→ Common Shares (5,000 underlying)
Holdings
- 10,917
common shares
- 6,800
Stock Options
Exercise: $3.39From: 2022-03-08Exp: 2027-03-08→ Common Shares (3,400 underlying) - 10,000
Stock Options
Exercise: $1.96From: 2022-10-12Exp: 2027-10-12→ Common Shares (3,200 underlying) - 15,000
Stock Options
Exercise: $0.87From: 2023-07-25Exp: 2028-07-25→ Common Shares (5,000 underlying) - 3,400
Stock Options
Exercise: $3.00From: 2021-02-01Exp: 2026-02-01→ Common Shares (3,400 underlying)
Footnotes (1)
- [F1]Repriced from $4.80 pursuant to shareholder approval received on May 9, 2023
Documents
Issuer
Lexaria Bioscience Corp.
CIK 0001348362
Entity typeother
Related Parties
1- filerCIK 0001244736
Filing Metadata
- Form type
- 4
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 4:52 PM ET
- Size
- 10.7 KB